Therapeutic vaccination for closed head injury

被引:38
作者
Kipnis, J
Nevo, U
Panikashvili, D
Alexandrovich, A
Yoles, E
Akselrod, S
Shohami, E
Schwartz, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
[2] Tel Aviv Univ, Sch Phys & Astron, Dept Med Phys, IL-69978 Tel Aviv, Israel
[3] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel
关键词
brain injury; autoimmune neuroprotection; strain differences; CNS inflammation; EAE-susceptibility; Cop-1 (Glatiramer acetate);
D O I
10.1089/089771503767168483
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Closed head injury often has a devastating outcome, partly because the insult, like other injuries to the central nervous system (CNS), triggers self-destructive processes. During studies of the response to other CNS insults, it was unexpectedly discovered that the immune system, if well controlled, provides protection against self-destructive activities. Here we show that in mice with closed head injury, the immune system plays a key role in the spontaneous recovery. Strain-related differences were observed in the ability to harness a T cell-dependent protective mechanism against the effects of the injury. We further show that the trauma-induced deficit could be reduced, both functionally and anatomically, by post-traumatic vaccination with Cop-1, a synthetic copolymer used to treat patients with multiple sclerosis and found (using a different treatment protocol) to effectively counteract the loss of neurons caused by axonal injury or glutamate-induced toxicity. We suggest that a compound such as Cop-1 can be safely developed as a therapeutic vaccine to boost the body's immune repair mechanisms, thereby providing multifactorial protection against the consequences of brain trauma.
引用
收藏
页码:559 / 569
页数:11
相关论文
共 68 条
[1]   Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking [J].
Aharoni, R ;
Teitelbaum, D ;
Arnon, R ;
Sela, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :634-639
[2]   Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1 [J].
Aharoni, R ;
Teitelbaum, D ;
Sela, M ;
Arnon, R .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 91 (1-2) :135-146
[3]   Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis [J].
Aharoni, R ;
Teitelbaum, D ;
Sela, M ;
Arnon, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10821-10826
[4]   Oral treatment of mice with copolymer 1 (glatiramer acetate) results in the accumulation of specific Th2 cells in the central nervous system [J].
Aharoni, R ;
Meshorer, A ;
Sela, M ;
Arnon, R .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 126 (1-2) :58-68
[5]   Immune regulation and CNS autoimmune disease [J].
Antel, JP ;
Owens, T .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :181-189
[6]   Diffusion and perfusion magnetic resonance imaging following closed head injury in rats [J].
Assaf, Y ;
Holokovsky, A ;
Berman, E ;
Shapira, Y ;
Shohami, E ;
Cohen, Y .
JOURNAL OF NEUROTRAUMA, 1999, 16 (12) :1165-1176
[7]   Molecular pathogenesis of multiple sclerosis [J].
Bar-Or, A ;
Oliveira, EML ;
Anderson, DE ;
Hafler, DA .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :252-259
[8]   Review of current evidence for apoptosis after spinal cord injury [J].
Beattie, MS ;
Farooqui, AA ;
Bresnahan, JC .
JOURNAL OF NEUROTRAUMA, 2000, 17 (10) :915-925
[9]  
Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57
[10]  
BENNUN A, 1982, J IMMUNOL, V129, P303